Registered number
14885315
Maheen Healthcare Limited
Filleted Accounts
31 May 2024
Maheen Healthcare Limited
Registered number: 14885315
Balance Sheet
as at 31 May 2024
Notes 2024
£
Fixed assets
Tangible assets 3 2,939
Current assets
Cash at bank and in hand 19,958
Creditors: amounts falling due within one year 4 (22,781)
Net current liabilities (2,823)
Net assets 116
Capital and reserves
Called up share capital 2
Profit and loss account 114
Shareholders' funds 116
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr M. Q. J. Khattak
Director
Approved by the board on 31 August 2024
Maheen Healthcare Limited
Notes to the Accounts
for the year ended 31 May 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery 20% reducing balance
Fixtures, fittings, tools and equipment 20% reducing balance
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
2 Employees 2024
Number
Average number of persons employed by the company 1
3 Tangible fixed assets
Plant and equipment etc
£
Cost
Additions 3,674
At 31 May 2024 3,674
Depreciation
Charge for the year 735
At 31 May 2024 735
Net book value
At 31 May 2024 2,939
4 Creditors: amounts falling due within one year 2024
£
Taxation and social security costs 9,427
Other creditors 13,354
22,781
5 Related party transactions
There are no related party transactions to disclose.
6 Controlling party
The company is controlled by the director, Dr M. Khattak, and his spouse, Mrs G. Rahim, by virtue of them holding 100% of the ordinary share capital.
7 Other information
Maheen Healthcare Limited is a private company limited by shares and incorporated in England. Its registered office is:
19 Ewing Gardens
Langdon Hills
Basildon
Essex
SS16 5PY
Maheen Healthcare Limited 14885315 false 2023-06-01 2024-05-31 2024-05-31 VT Final Accounts April 2024 Dr M. Q. J. Khattak No description of principal activity 14885315 2023-06-01 2024-05-31 14885315 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 14885315 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 14885315 bus:Director40 2023-06-01 2024-05-31 14885315 1 2023-06-01 2024-05-31 14885315 2 2023-06-01 2024-05-31 14885315 countries:England 2023-06-01 2024-05-31 14885315 bus:FRS102 2023-06-01 2024-05-31 14885315 bus:FilletedAccounts 2023-06-01 2024-05-31 14885315 2024-05-31 14885315 core:WithinOneYear 2024-05-31 14885315 core:ShareCapital 2024-05-31 14885315 core:RetainedEarningsAccumulatedLosses 2024-05-31 14885315 2023-05-31 iso4217:GBP xbrli:pure